A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.
from Top Health News -- ScienceDaily https://ift.tt/qxPGISg
No comments:
Post a Comment